(BLOOMBERG) — The ReCIVA (as in “respiration collector for in vitro analysis”) breath sampler can detect the kinds of volatile organic compounds (VOCs) in people’s breath that are early indicators of lung cancer, colon cancer, and other diseases.

It’s meant to substitute for costlier, more invasive CT scans and biopsies.

Note: Read our discussion guidelines before commenting.